References
- Kohli HS, Sharma A, and Sood A, editors. Asia 2050: realizing the Asian century. New Delhi: SAGE Publications India; 2011. p. 1.
- Patel R, Patel A, Gohil T. Regulatory requirement for the approval of generic drug in Cambodia as per ASEAN Common Technical Dossier (ACTD). Int J Drug Reg Affairs. 2018;6(2):67–71. http://ijdra.com/index.php/journal/article/view/245
- Jakovljevic M, Lamnissos D, Westerman R, et al. Future health spending forecast in leading emerging BRICS markets in 2030-health policy implications. 2021. DOI:https://doi.org/10.21203/rs.3.rs-666830/v1
- Galen Growth Asia. Healthtech investment report. 2018. Available from: https://blog.galengrowth.com/ht-funding-fy-2018.
- Santillan VE. Asia pacific and its impact on the global pharmaceutical industry. 2019. Available from: https://ispe.org/pharmaceutical-engineering/ispeak/asia-pacific-and-its-impact-global-pharmaceutical-industry.
- McKinsey Global Institute. The future of Asia: decoding the value and performance of corporate Asia. New York: McKinsey Global Institute; 2020.
- Statista. Market growth forecast for certain pharmaceutical markets between 2019 and 2024. 2021.
- Statista, 2021. Projected global pharmaceutical market growth between 2019 and 2024, by region. Available from: https://www.statista.com/statistics/299702/world-pharmaceutical-market-growth-by-region-forecast/
- L.E.K. Special report: expanding into Asia-Pacific – life sciences opportunities and strategies for success. L.E.K. Consulting LLC; 2019. Available from: https://www.lek.com/insights/life-sciences-expansion-apac
- CPhI Southeast Asia report: executives call for track-and-trace schemes. 2020. Available from: https://cleanroomtechnology.com/news/article_page/CPhI_Southeast_Asia_Report_Executives_call_for_track-and-trace_schemes/161924.
- Kakkar V, Saini K. Outlook for Asian pharmaceutical industry. 2020. Available from: http://www.pharmabiz.com/NewsDetails.aspx?aid=121681&sid=21.
- Jakovljevic M, Timofeyev Y, Ranabhat CL, et al. Real GDP growth rates and healthcare spending–comparison between the G7 and the EM7 countries. Global Health. 2020;16(1):1–13.
- ACHEON Working Group; Kim Y-C, Ahn JS, Calimag MMP, et al. Current practices in cancer pain management in Asia: a survey of patients and physicians across 10 countries. Cancer Med. 2015;4(8):1196–1204.
- Ranabhat CL, Atkinson J, Park MB, et al. The influence of universal health coverage on life expectancy at birth (LEAB) and healthy life expectancy (HALE): a multi-country cross-sectional study. Front Pharmacol. 2018;9:960.
- Jakovljevic M, Sugahara T, Timofeyev Y, et al. Predictors of (in) efficiencies of healthcare expenditure among the leading Asian economies–comparison of OECD and non-OECD nations. RMHP. 2020;13:2261–2280.
- Ramli N, Amin N, Zawawi M, et al. Healthcare service: halal pharmaceutical in Malaysia, issues and challenges. Malaysian J Consum Fam Econ. 2018;20(S1):101–111.
- Lane EJ. Pharma market bets on ASEAN in focus ahead of economic pact. 2015. Available from: https://www.fiercepharma.com/manufacturing/pharma-market-bets-on-asean-focus-ahead-of-economic-pact.
- Ghosh PK. Novel active pharmaceutical ingredients from India: the actors-part-I. MGM J Med Sci. 2021;8(1):73.
- Yu PK. China's innovative turn and the changing pharmaceutical landscape. U Pac L Rev. 2019;51:593.
- Site selection for life sciences companies: Asia – KPMG. 2020. Available from: https://home.kpmg/ch/en/home/insights/2020/07/site-selection-for-life-sciences-companies-in-asia.html.
- How pharmaceutical systems are organized in Asia and The Pacific. Geneva: World Health Organization/Organisation for Economic Co-operation and Development; 2018.
- Vietnam’s medical devices industry: key market entry considerations. 2021. Available from: https://www.vietnam-briefing.com/news/vietnams-medical-devices-industry-key-market-entry-considerations.html/.
- Future Health Index 2019 Transforming healthcare experiences; Philips' fourth annual Future Health Index, based on a survey of 15,000 individuals and more than 3,100 healthcare professionals in 15 countries. Available from: https://images.philips.com/is/content/PhilipsConsumer/Campaigns/CA20162504_Philips_Newscenter/Philips_Future_Health_Index_2019_report_transforming_healthcare_experiences.pdf.
- The Asian Federation for Pharmaceutical Sciences (AFPS). Available from: https://www.afps2007.org/.
- Santillan VE. Asia Pacific and its impact on the global pharmaceutical industry. Available from: 2019. https://ispe.org/pharmaceutical-engineering/ispeak/asia-pacific-and-its-impact-global-pharmaceutical-industry.
- Thambavita D, Galappatthy P, Jayakody RL. Regulatory requirements for the registration of generic medicines and format of drug dossiers: procedures in Sri Lanka in comparison with selected regulatory authorities. J of Pharm Policy and Pract. 2018;11(1):1–8.
- Thavorn J, Klongthong W, Watcharadamrongkun S, et al. The impact of wisdom and pharmaceutical care on the corporate identity of Thai pharmacy retail stores. J Asian Fin Econ Business. 2021;8(1):317–326.
- Pattharapinyophong W. The opportunities and challenges for Thailand in becoming the medical tourism hub of the ASEAN region. J Manage Sci Suratthani Rajabhat Univ. 2019;6(1):1–16.
- Jabeen S, Sridhar S, Balamuralidhara V. Drug recall procedure in ASEAN countries. Res J Pharm Technol. 2019; 12(12):6041–6048. https://rjptonline.org/HTMLPaper.aspx?Journal=Research%20Journal%20of%20Pharmacy%20and%20Technology;PID=2019-12-12-72
- Quet M, Pordié L, Bochaton A, et al. Regulation multiple: pharmaceutical trajectories and modes of control in the ASEAN. Sci Technol Soc. 2018;23(3):485–503. https://doi.org/https://doi.org/10.1177/0971721818762935
- Hock SC. Harmonization of GMP inspection and benefits to ASEAN economic community. 2021. Available from: https://globalforum.diaglobal.org/issue/march-2021/harmonization-of-gmp-inspection-and-benefits-to-asean-economic-community/.
- Tongia A. The drug regulatory landscape in the ASEAN region. 2018. Available from: https://www.raps.org/news-and-articles/news-articles/2018/1/the-drug-regulatory-landscape-in-the-asean-region.
- Wong J, Chan S. China's emergence as a global manufacturing Centre: implications for ASEAN. Asia Pacific Business Rev. 2002;9(1):79–94.f.
- Kondo H, Hata T, Ito K, et al. The current status of sakigake designation in Japan, PRIME in the European Union, and breakthrough therapy designation in the United States. Ther Innov Regul Sci. 2017;51(1):51–54.
- Jakovljevic MB, Nakazono S, Ogura S. Contemporary generic market in Japan–key conditions to successful evolution. Exp Rev Pharmacoecon Outcomes Res. 2014;14(2):181–194.
- Hashimoto J, Ueda E, Narukawa M. The current situation of oncology drug lag in Japan and strategic approaches for pharmaceutical companies. Drug Information J. 2009;43(6):757–765.
- Li X, Yang Y. The drug lag issue: a 20-year review of China. Invest New Drugs. 2021;39(5):1389–1310.
- Hall R. The most exciting region in Asia for pharma and medical devices. 2017. Available from: https://www.lifescienceleader.com/doc/the-most-exciting-region-in-asia-for-pharma-and-medical-devices-0001.
- Hidayati N, Almasdy D, Putra AS. Global trade and health: an Indonesian perspective on the Asean medical device directive policy. BKM J Commun Med Public Health. 2021;37(1):1–6.
- Competition and profitability of pharmaceuticals in Asia. 2016. Available from: https://aseanup.com/competition-profitability-pharmaceuticals-asia/.
- First remote surgery in China conducted using 5G technology. https://www.globaltimes.cn/content/1142340.shtml.
- Munir Z. A Pharma Playbook for Success in Southeast Asia. 2016. https://www.bcg.com/publications/2016/pharma-playbook-success-southeast-asia.
- Statista Research Department. Market size of the medical devices market in the Asia/Pacific region from 2016 to 2020(in billion U.S. dollars). 2016. Available from: https://www.statista.com/statistics/717156/asia-pacific-region-medical-devices-market-size/.
- Asia-Pacific $486.72Bn Healthcare Industry Outlook, 2019. Cell therapy to emerge as leading market across regenerative medicine. ResearchAndMarkets.com, 2019. Available from: https://www.businesswire.com/news/home/20190320005277/en/Asia-Pacific-486.72Bn-Healthcare-Industry-Outlook-2019–-Cell-Therapy-to-Emerge-as-Leading-Market-Across-Regenerative-Medicine–-ResearchAndMarkets.com.
- Asia Pacific remote patient monitoring systems market share, size 2021 global statistics, growth factors, industry trends, competition strategies, revenue analysis, key players, regional analysis by forecast to 2024. 2021. Available from: https://www.newschannelnebraska.com/story/43737119/Asia%20Pacific%20Remote%20Patient%20Monitoring%20Systems%20Market%20Share,Size%202021%20Global%20Statistics,%20Growth%20Factors,%20Industry%20Trends,%20Competition%20Strategies,%20Revenue%20Analysis,%20Key%20Players,%20Regional%20Analysis%20by%20Forecast%20to%202024.
- Asia-Pacific general surgical devices market – growth, trends, COVID-19 impact, and forecasts (2021–2026). Available from: https://www.mordorintelligence.com/industry-reports/asia-pacific-general-surgical-devices-marke.
- Asia-Pacific Medical Devices Market – Industry Trends and Forecast to 2028; https://www.databridgemarketresearch.com/reports/asia-pacific-medical-devices-market.
- Agarwal A, Then F, Wu K. The rise and rise of Medtech in Asia. 2018. Available from: https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/the-rise-and-rise-of-medtech-in-asia#.
- Burton P. Medtech’s Post-COVID paradigm in APAC. 2021. Available from: https://pharmaboardroom.com/articles/medtechs-post-covid-paradigm-in-apac/.
- Gauttam P, Patel N, Singh B, et al. Public health policy of India and COVID-19: diagnosis and prognosis of the combating response. Sustainability. 2021;13(6):3415.
- Krstic K, Westerman R, Chattu VK, et al. Corona-triggered global macroeconomic crisis of the early 2020s. IJERPH. 2020;17(24):9404.
- APAC healthcare sector opportunities grow as economies recover. 2021. Available from: https://www.business-sweden.com/insights/articles/APAC-healthcare-sector-opportunities/.
- Ganapathy K, Nukala L, Premanand S, et al. Telemedicine in camp mode while screening for noncommunicable diseases: a preliminary report from India. Telemed J E Health. 2020;26(1):42–50.
- Zhang H, Li J, Wen B, et al. Connecting intelligent things in smart hospitals using NB-IoT. IEEE Internet Things J. 2018;5(3):1550–1560.
- Ho CW-L, Caals K, Zhang H. Heralding the digitalization of life in post-pandemic East Asian societies. J Bioeth Inq. 2020;17(4):657–661. "
- Park J, Kim M. 2013, October. A study on the potential needs and market promotion of smart health in Korea. 2013 International Conference on ICT Convergence (ICTC). IEEE. p. 824–825.
- Rasoulian-Kasrineh M, Sharifzadeh N, Tabatabaei S-M. Smart hospitals around the world: a systematic review. 2021. Available from: https://www.researchsquare.com/article/rs-258174/latest.pdf. https://doi.org/https://doi.org/10.21203/rs.3.rs-258174/v1
- Yun G, Zhaoyi P, Qingqing C. China performs first 5G-based remote surgery on human brain. 2019. Available from: https://news.cgtn.com/news/3d3d774d7945444e33457a6333566d54/index.html.
- ASEAN investment report 2019 – FDI in services: focus on health care. Jakarta: ASEAN Secretariat; 2019.
- Chakraborty D, Chaisse J, Xu QIAN. Is it finally time for India's free trade agreements? The ASEAN “present” and the RCEP “future”. AsianJIL. 2019;9(2):359–391.
- Xi K. Asia-Pacific: world’s largest trade deal’s pharma impact too early to tell. 2020. https://pharmaboardroom.com/articles/asia-pacific-worlds-largest-trade-deals-pharma-impact-too-early-to-tell/.
- Shimizu K. The ASEAN economic community and the RCEP in the world economy. J Contemp East Asia Stud. 2021;10(1):1–23.
- Zhang Q, Fan Y. Comparative analysis of the tax burden level of RCEP countries. J Front Soc Sci Technol. 2021;1(6):35–41.
- UN DESA. Jointly building the “belt and road” towards the sustainable development goals. Available from: https://www.un.org/en/desa/jointly-building-%E2%80%9Cbelt-and-road%E2%80%9D-towards-sustainable-development-goals.
- Cao J. Toward a health silk road: China’s proposal for global health cooperation. China Q Int Strategic Stud. 2020;06(01):19–35. Available from: https://doi.org/https://doi.org/10.1142/S2377740020500013
- Tilman H, Ye Y, Jian Y. Health Silk Road 2020: a bridge to the future of health for all. 2021. Available from: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3830380.
- Ramesh T, Saravanan D, Khullar P. Regulatory perspective for entering global pharma markets. Pharma Times. 2011;43(9):15–20.
- Danieles A. South Korea to build a biomedical cluster in Seoul. 2016. https://clustercollaboration.eu/news/south-korea-build-biomedical-cluster-seoul.
- Schmid RD, Xiong X. Biotech in China 2021, at the beginning of the 14th five-year period (“145”). Appl Microbiol Biotechnol. 2021;105(10):3971–3915.
- Pharma 50: the 50 largest pharmaceutical companies in the world. Available from: https://www.drugdiscoverytrends.com/pharma-50-the-50-largest-pharmaceutical-companies-in-the-world/.
- Pharma 25 2021 Ranking. Available from: https://brandirectory.com/rankings/pharma/.
- Chongsuvivatwong V, Phua KH, Yap MT, et al. Health and health-care systems in Southeast Asia: diversity and transitions. Lancet. 2011;377(9763):429–437.